Special Issue "Global Antimicrobial Resistance: What Are the Current Emerging Threats?"
Deadline for manuscript submissions: 31 January 2021.
Interests: antimicrobial resistance; carbapenemases; bacterial genomics; molecular epidemiology; multidrug resistant Gram-negative bacteria; Klebsiella pneumoniae
Antimicrobial resistance (AMR) is a complex public health challenge impacting all regions of the world. In addition to being a natural evolutionary phenomenon, AMR is increasingly being accelerated by selective pressure exerted as a result of the use and misuse of antibiotics in humans and animals. Fighting this threat is a priority that requires a global approach across multiple sectors beyond healthcare, including the food supply chain (e.g., antibiotics are known to be used for growth promotion) and the environment (e.g., interconnection through medical and agricultural waste that ultimately permeates water and soil).
The scientific community has made significant advances in increasing their knowledge about the most urgent threats, primarily in clinical settings (e.g., ESKAPE organisms, high-risk clones, etc.); however new mechanisms and new emerging bacterial threats are constantly being discovered within these as well as other settings.
With this global approach in mind, this Special Issue seeks submissions highlighting the new threats that we need to be on the lookout for: novel antibiotic resistance mechanisms, emerging pathogens, novel ‘high-risk clones’, or increasing rates of resistance in organisms previously considered less of a concern, especially from regions of the world where epidemiological data are scarce.
Dr. Laura J. Rojas
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- emerging antimicrobial resistance mechanisms
- emerging pathogens
- molecular epidemiology
- low- and middle-income countries